Intravenous rt-PA is not associated with increased risk of hemorrhage in patients with intracranial aneurysms

Neurocritical Care

Volumn 17, Issue 2, 2012, Pages 199-203

  Sheth, Kevin N ^a   Shah, Nikeith ^a   Morovati, Tanya ^b   Hermann, Lisa D ^c   Cronin, Carolyn A ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

Acute stroke; Thrombolysis

Indexed keywords

ALTEPLASE; ANTITHROMBOCYTIC AGENT; WARFARIN;

ADULT; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HUMAN; INCIDENTAL FINDING; INTERNATIONAL NORMALIZED RATIO; INTRACRANIAL ANEURYSM; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SACCULAR ANEURYSM; SYMPTOMATOLOGY;

AGED; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; COHORT STUDIES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INTRACRANIAL ANEURYSM; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84869220567     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-012-9734-9     Document Type: Article

References (19)

1. The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke. 1997;28:2109-18.
2. Demchuk AM, Morgenstern LB, Krieger DW, Linda Chi T, Hu W, Wein TH, et al. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke. 1999;30:34-9. (Pubitemid 29029438)
3. Heuschmann PU, Kolominsky-Rabas PL, Roether J, Misselwitz B, Lowitzsch K, Heidrich J, et al. German Stroke Registers Study Group. Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy. JAMA. 2004;20:1831-8. (Pubitemid 40169293)
4. Tanne D, Kasner SE, Demchuk AM, Koren-Morag N, Hanson S, Grond M, et al. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the multicenter rt-PA stroke survey. Circulation. 2002;105: 1679-85. (Pubitemid 34298612)
5. Adams H, Adams R, Del Zoppo G, Goldstein LB, Stroke Council of the American Heart Association, American Stroke Association. Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the stroke council of the american heart Association/American stroke association. Stroke. 2005;2005(36):916-23.
6. US Food and Drug Administration. http://www.fda.gov/Drugs/ DevelopmentApprovalProcess/HowDrugsareDevelopedand Approved/ ApprovalApplications/TherapeuticBiologicApplications/ucm080432.htm (2011). Accessed 27 Aug 2011.
7. Vlak MH, Algra A, Brandenburg R, Rinkel GJ. Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. Lancet Neurol. 2011;10:626-36.
8. Latchaw RE, Alberts MJ, Lev MH, Connors JJ, Harbaugh RE, Higashida RT. American Heart Association Council on cardiovascular radiology and intervention, stroke council, and the interdisciplinary council on peripheral vascular disease. Recommendations for imaging of acute ischemic stroke: a scientific statement from the American Heart Association. Stroke. 2009; 40:3646-78.
9. Sims JR, Gharai LR, Schaefer PW, Vangel M, Rosenthal ES, Lev MH, et al. ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology. 2009;72:2104-10.
10. Wardlaw JM, White PM. The detection and management of unruptured intracranial aneurysms. Brain. 2000;123:205-21. (Pubitemid 30055146)
11. Wiebers DO, Whisnant JP, Sundt TM Jr, O'Fallon WM. The significance of unruptured intracranial saccular aneurysms. J Neurosurg. 1987;66:23-9. (Pubitemid 17214277)
12. Wiebers DO, Whisnant JP, Huston J III, Meissner I, Brown RD Jr, Piepgras DG, et al. International study of unruptured intracranial aneurysms investigators. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet. 2003;362:103-10. (Pubitemid 36831019)
13. Oh YS, Lee SJ, Shon YM, Yang DW, Kim BS, Cho AH. Incidental unruptured intracranial aneurysms in patients with acute ischemic stroke. Cerebrovasc Dis. 2008;26:650-3.
14. del Zoppo GJ, von Kummer R, Hamann GF. Ischemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke. J Neurol Neurosurg Psychiatry. 1998;65:1-9. (Pubitemid 28302350)
15. Kane I, Sandercock P, Thomas B. Can patients with unruptured intracranial aneurysms be treated with thrombolysis? Cerebrovasc Dis. 2005;20:51-2. (Pubitemid 41003638)
16. Sloan MA, Price TR, Petito CK, Randall AM, Solomon RE, Terrin ML, et al. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the thrombolysis in myocardial infarction (TIMI) II pilot and randomized clinical trial combined experience. Neurology. 1995;45:649-58.
17. Ogawa A, Mori E, Minematsu K, Taki W, Takahashi A, Nemoto S, et al. MELT Japan Study Group. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT). Stroke. 2007;38:2633-9. (Pubitemid 47493996)
18. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS study: a randomized controlled trial. alteplase thrombolysis for acute noninterventional therapy in ischemic stroke. JAMA. 1999;282:2019-26.
19. Edwards NJ, Kamel H, Josephson SA. The safety of intravenous thrombolysis for ischemic stroke in patients with pre-existing cerebral aneurysms: a case series and review of the literature. Stroke. 2012;43:412-6.